HEADER NUCLEAR PROTEIN 09-NOV-20 7AXA TITLE CRYSTAL STRUCTURE OF THE HPXR-LBD IN COMPLEX WITH CLOTRIMAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1,ORPHAN NUCLEAR RECEPTOR PXR, COMPND 5 PREGNANE X RECEPTOR,STEROID AND XENOBIOTIC RECEPTOR,SXR; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET11 KEYWDS NUCLEAR RECEPTOR HORMONE RECEPTOR PREGNANE X RECEPTOR, NUCLEAR KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR V.DELFOSSE,M.GRANELL,P.BLANC,W.BOURGUET REVDAT 2 31-JAN-24 7AXA 1 REMARK REVDAT 1 13-JAN-21 7AXA 0 JRNL AUTH V.DELFOSSE,T.HUET,D.HARRUS,M.GRANELL,M.BOURGUET, JRNL AUTH 2 C.GARDIA-PAREGE,B.CHIAVARINA,M.GRIMALDI,S.LE MEVEL,P.BLANC, JRNL AUTH 3 D.HUANG,J.GRUSZCZYK,B.DEMENEIX,S.CIANFERANI,J.B.FINI, JRNL AUTH 4 P.BALAGUER,W.BOURGUET JRNL TITL MECHANISTIC INSIGHTS INTO THE SYNERGISTIC ACTIVATION OF THE JRNL TITL 2 RXR-PXR HETERODIMER BY ENDOCRINE DISRUPTOR MIXTURES. JRNL REF PROC.NATL.ACAD.SCI.USA V. 118 2021 JRNL REFN ESSN 1091-6490 JRNL PMID 33361153 JRNL DOI 10.1073/PNAS.2020551118 REMARK 2 REMARK 2 RESOLUTION. 2.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18_3845 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.67 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 17437 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 872 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.6700 - 4.1100 0.99 2934 155 0.1730 0.1956 REMARK 3 2 4.1100 - 3.2600 0.98 2750 145 0.1745 0.2384 REMARK 3 3 3.2600 - 2.8500 1.00 2779 146 0.1982 0.2704 REMARK 3 4 2.8500 - 2.5900 0.99 2727 143 0.2077 0.2437 REMARK 3 5 2.5900 - 2.4000 1.00 2748 144 0.2051 0.2673 REMARK 3 6 2.4000 - 2.2600 0.96 2627 139 0.2292 0.3022 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.252 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.859 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.57 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2311 REMARK 3 ANGLE : 0.941 3142 REMARK 3 CHIRALITY : 0.045 343 REMARK 3 PLANARITY : 0.006 450 REMARK 3 DIHEDRAL : 21.239 894 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7AXA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1292112139. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-APR-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 - 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.966 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17442 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.260 REMARK 200 RESOLUTION RANGE LOW (A) : 45.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.9500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.680 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 1ILG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 - 100 MM IMIDAZOLE 8 - 14% REMARK 280 ISOPROPANOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.15500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.67500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.67500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.73250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.67500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.67500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 21.57750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.67500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.67500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 64.73250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.67500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.67500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 21.57750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 43.15500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 91.35000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 91.35000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -43.15500 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 119 REMARK 465 LYS A 120 REMARK 465 LYS A 121 REMARK 465 GLY A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 HIS A 127 REMARK 465 HIS A 128 REMARK 465 GLY A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 GLN A 141 REMARK 465 LEU A 178 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 SER A 192 REMARK 465 ARG A 193 REMARK 465 GLU A 194 REMARK 465 THR A 311 REMARK 465 ALA A 312 REMARK 465 GLY A 313 REMARK 465 GLY A 314 REMARK 465 PHE A 315 REMARK 465 VAL A 436 REMARK 465 PRO A 437 REMARK 465 ARG A 438 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 152 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 195 CG CD OE1 OE2 REMARK 470 ARG A 203 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 204 CG CD CE NZ REMARK 470 GLU A 218 CG CD OE1 OE2 REMARK 470 LYS A 226 CD CE NZ REMARK 470 SER A 231 OG REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 ARG A 303 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 309 CG CD OE1 OE2 REMARK 470 ASP A 310 CG OD1 OD2 REMARK 470 GLN A 316 CG CD OE1 NE2 REMARK 470 GLN A 317 CG CD OE1 NE2 REMARK 470 LEU A 318 CG CD1 CD2 REMARK 470 LEU A 319 CG CD1 CD2 REMARK 470 LYS A 325 CE NZ REMARK 470 LYS A 332 CE NZ REMARK 470 ARG A 360 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 680 O HOH A 753 2.05 REMARK 500 ND2 ASN A 404 O HOH A 601 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 196 -72.69 68.02 REMARK 500 CYS A 301 68.65 -107.00 REMARK 500 LEU A 319 -7.13 -59.95 REMARK 500 PHE A 349 48.28 -93.97 REMARK 500 ASP A 352 30.62 -99.98 REMARK 500 PHE A 420 -14.14 -153.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 768 DISTANCE = 6.16 ANGSTROMS REMARK 525 HOH A 769 DISTANCE = 6.35 ANGSTROMS REMARK 525 HOH A 770 DISTANCE = 8.54 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL6 A 501 DBREF 7AXA A 130 434 UNP O75469 NR1I2_HUMAN 130 434 SEQADV 7AXA MET A 119 UNP O75469 INITIATING METHIONINE SEQADV 7AXA LYS A 120 UNP O75469 EXPRESSION TAG SEQADV 7AXA LYS A 121 UNP O75469 EXPRESSION TAG SEQADV 7AXA GLY A 122 UNP O75469 EXPRESSION TAG SEQADV 7AXA HIS A 123 UNP O75469 EXPRESSION TAG SEQADV 7AXA HIS A 124 UNP O75469 EXPRESSION TAG SEQADV 7AXA HIS A 125 UNP O75469 EXPRESSION TAG SEQADV 7AXA HIS A 126 UNP O75469 EXPRESSION TAG SEQADV 7AXA HIS A 127 UNP O75469 EXPRESSION TAG SEQADV 7AXA HIS A 128 UNP O75469 EXPRESSION TAG SEQADV 7AXA GLY A 129 UNP O75469 EXPRESSION TAG SEQADV 7AXA LEU A 435 UNP O75469 EXPRESSION TAG SEQADV 7AXA VAL A 436 UNP O75469 EXPRESSION TAG SEQADV 7AXA PRO A 437 UNP O75469 EXPRESSION TAG SEQADV 7AXA ARG A 438 UNP O75469 EXPRESSION TAG SEQRES 1 A 320 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 A 320 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 A 320 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 A 320 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 A 320 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 A 320 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 A 320 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 A 320 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 A 320 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 A 320 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 A 320 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 A 320 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 A 320 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 A 320 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 A 320 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 A 320 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 A 320 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 A 320 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 A 320 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 A 320 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 A 320 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 A 320 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 A 320 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 A 320 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 A 320 ILE THR GLY SER LEU VAL PRO ARG HET CL6 A 501 50 HETNAM CL6 1-[(2-CHLOROPHENYL)(DIPHENYL)METHYL]-1H-IMIDAZOLE HETSYN CL6 CLOTRIMAZOLE FORMUL 2 CL6 C22 H17 CL N2 FORMUL 3 HOH *170(H2 O) HELIX 1 AA1 THR A 144 PHE A 162 1 19 HELIX 2 AA2 ALA A 196 LEU A 209 1 14 HELIX 3 AA3 GLY A 233 SER A 238 5 6 HELIX 4 AA4 LEU A 239 ILE A 261 1 23 HELIX 5 AA5 ILE A 261 LEU A 267 1 7 HELIX 6 AA6 PRO A 268 VAL A 291 1 24 HELIX 7 AA7 GLN A 317 LEU A 320 5 4 HELIX 8 AA8 GLU A 321 LEU A 333 1 13 HELIX 9 AA9 HIS A 336 PHE A 349 1 14 HELIX 10 AB1 GLN A 358 ARG A 381 1 24 HELIX 11 AB2 GLN A 383 ARG A 387 5 5 HELIX 12 AB3 PHE A 388 HIS A 418 1 31 HELIX 13 AB4 THR A 422 GLY A 430 1 9 SHEET 1 AA1 5 VAL A 222 TYR A 225 0 SHEET 2 AA1 5 VAL A 211 ARG A 216 -1 N LEU A 213 O TYR A 225 SHEET 3 AA1 5 LEU A 304 LEU A 308 -1 O SER A 305 N GLN A 214 SHEET 4 AA1 5 THR A 298 CYS A 301 -1 N TRP A 299 O TYR A 306 SHEET 5 AA1 5 PHE A 292 ASN A 293 -1 N ASN A 293 O THR A 298 SITE 1 AC1 13 SER A 208 LEU A 209 VAL A 211 SER A 247 SITE 2 AC1 13 GLN A 285 PHE A 288 TRP A 299 TYR A 306 SITE 3 AC1 13 MET A 323 LEU A 324 HIS A 327 HIS A 407 SITE 4 AC1 13 HOH A 729 CRYST1 91.350 91.350 86.310 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010947 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010947 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011586 0.00000